News from the Chromicent

Dear customers and friends of Chromicent,

We hope you have had a good start to 2022.

At Chromicent, the start of the new year is marked by challenges and exciting assignments – and it is our pleasure to keep you up to date with the latest developments in our laboratory.

Nitrosamine analysis is an integral part of our service portfolio. In our latest and third publication, we focus on the development of a method that can be used during the development of medicinal products even before approval and also in risk assessment after authorisation, in order to consistently avoid out-of-specification (OOS) results in the future – and thus open up a perspective for the future.
Further topics:

The implementation of a laboratory and management system LIMS, which enables us to take into account the increased requirements for data integrity.

In our core competence MCLM, we are focusing on Stage 3 this year – by expanding stability and release testing.

In this context, we would also like to refer to our established event in cooperation with Concept Heidelberg. The Lifecycle Management of Analytical Methods” will take place on

1 0 . / 1 1 . M a i 2 0 2 – l i v e o n l i n e

 – exclusively in German. We look forward to seeing you there.

You can download the information letter directly here.

We wish you a successful spring and look forward to common challenges

Mijo Stanic and Dr Alexander H. Schmidt